Product
IRE plus Checkpoint Inhibitor plus CpG-ODN
1 clinical trial
1 indication
Indication
Liver Metastasis Colon CancerClinical trial
Immune Response to Irreversible Electroporation (NanoKnife ®) and a Checkpoint Inhibitor With or Without CpG Oligodeoxynucleotides for the Treatment of Stage IV Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2026-12-01